The Metric We Are Missing: Measuring Public Health Beyond Just Billions of Doses
When 1 in 100,000 adverse events means an entire city of forgotten patients.
When we talk about global public health measures, success is almost always measured in massive numbers. To date, an incredible 13.53 billion COVID-19 vaccine doses have been administered globally. There is no denying that the vaccines worked on a macro scale, and that structural truth must remain absolutely clear. However, true scientific integrity demands that we hold two complex truths at the same exact time.
According to a massive 2024 multinational study of 99 million vaccinated individuals, researchers confirmed rare but highly significant elevated rates of:
While public health institutions rightly argue that the macro-level benefits far outweigh the statistical risks, we must understand that a risk labeled “rare” is never negligible for the actual human being living inside that reality.
UK Vaccine Damage Payment Scheme Data:
┌──────────────────────────────────────┐
│ Total Claims: 16,030 │
├──────────────────────────────────────┤
│ Approved Claims: 192 │
├──────────────────────────────────────┤
│ Approval Rate: ~1.2% │
└──────────────────────────────────────┘
Look closely at the data from the UK Vaccine Damage Payment Scheme: out of 16,030 claims, only 192 have been approved—a tiny 1.2% approval rate.
To the average observer, these numbers seem small enough to ignore. But let’s look at the real math: across 13.53 billion doses, even a tiny 1 in 100,000 chance of a severe adverse event translates directly to 135,000 people. To put that into perspective, that is a population larger than the entire city of Cambridge, UK. We are not dealing with a minor footnote in a medical journal; we are dealing with the size of an entire city of suffering individuals.
